Management & Regulatory

Single-Use Tech in Biopharma: Cost, Eco-Friendly, and Flexible
Management & Regulatory Single-Use Tech in Biopharma: Cost, Eco-Friendly, and Flexible

In a decisive response to safeguard the stability of the financial system, the United States government has stepped forward with a bold assurance directed at customers of the recently collapsed Silicon Valley Bank (SVB). Officials have made a clear commitment that starting Monday, those affected

NIIMBL Invests $10M in Biopharma Manufacturing Innovation
Management & Regulatory NIIMBL Invests $10M in Biopharma Manufacturing Innovation

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently announced an ambitious new program, Project Call 7.1, to stimulate advancement in biopharmaceutical production and broaden workforce capabilities. With a funding pool of around $10 million, NIIMBL plans

How Does BeCrop Unlock Soil Secrets for Sustainable Farming?
Management & Regulatory How Does BeCrop Unlock Soil Secrets for Sustainable Farming?

As the pressure mounts to produce food sustainably, advancements in soil technology like BeCrop are critical. Developed by Biome Makers, BeCrop doesn't just analyze soil; it offers a comprehensive picture of the microbial ecosystem that is crucial for soil health and plant growth. With this

Corporate Action Key to Boosting Carbon Market Efficacy
Management & Regulatory Corporate Action Key to Boosting Carbon Market Efficacy

At the cusp of climate crisis mitigation, carbon markets stand as a crucial mechanism in the battle to replenish forests and slash greenhouse emissions. Yet, their functionality hinges on the corporate world's engrossment. The recent "Financing Forest Protection" digital roundtable by Greenhouse

Biotech: Key to Sustainable Agriculture Amid Climate Crisis
Management & Regulatory Biotech: Key to Sustainable Agriculture Amid Climate Crisis

As the shadow of climate change extends, sustainable farming is no longer optional but essential. With the world grappling with depleting resources and escalating food demand, breakthroughs in biotech stand at the forefront of agricultural innovation. These advancements herald a new era where

First Wave BioPharma CEO Sells Shares to Cover Tax Duties
Management & Regulatory First Wave BioPharma CEO Sells Shares to Cover Tax Duties

James Sapirstein, the CEO of First Wave BioPharma, Inc., recently conducted an insider transaction involving a modest number of company shares. He sold 174 shares at $4.2294 each, resulting in a total of approximately $735. However, this insider sale was not the outcome of voluntary market actions

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later